MedPath

Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas

Conditions
Parathyroid Adenomas
Registration Number
NCT07218224
Lead Sponsor
Thomas Hope
Brief Summary

This expanded access protocol is proposed to allow University of California San Francisco (UCSF) patients additional access to 18F-fluorocholine (FCH) Positron Emission Tomography (PET) imaging for localization of parathyroid adenomas.

Detailed Description

No health outcome measures will be obtained under this protocol.

Recruitment & Eligibility

Status
AVAILABLE
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  1. Age ≥ 13 years.
  2. Evidence of primary hyperparathyroidism.
  3. Ability to understand a written informed consent document, and the willingness to sign it.
Exclusion Criteria

1. Unlikely to comply with protocol procedures, restrictions and requirements and judged by the Investigator to be unsuitable for participation.

Study & Design

Study Type
EXPANDED_ACCESS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.